| Application no. and date | 17790401.8 (espacenet) (Federated) (European Patent Register), 20170427 | | Patent/reg. no. and date | DK/EP 3448391, 20240529 | | Publication date | 20190306 | | Priority no. and date | US 201662328539 P, 20160427 | | EP pub. no. and date |
EP 3448391 20190306 | | Effective date | | | Applicant/owner | AbbVie Manufacturing Management Unlimited Company, 70 Sir John Rogerson's Quay
Dublin, 2, IE | | Applicant ref. no. | P84743DK01 | | Inventor | TIMONY, Gregg, 7333 Calle Pera
Carlsbad, CA 92009, US,
GUJRATHI, Sheila, P.O. Box 1395
Rancho Santa Fe, CA 92067, US,
PEACH, Robert, 3415 6th Avenue
San Diego, CA 92103, US,
OLSON, Allan, 3033 Science Park Rd. Ste. 300
San Diego, CA 92121, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/56 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , C07K 16/24 (2006.01) | | Title | FREMGANGSMÅDER TIL BEHANDLING AF SYGDOMME MED SKADELIG IL-13-AKTIVITET UNDER ANVENDELSE AF ANTI-IL-13-ANTISTOFFER | | Int. application no. | US2017029768 | | Int. publication no. | WO2017189805 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
